A phase I study of MDM2 antagonist RG7112 in patients (pts) with relapsed/refractory solid tumors Meeting Abstract
| Authors: | Kurzrock, R.; Blay, J. Y.; Nguyen, B. B.; Wagner, A. J.; Maki, R. G.; Schwartz, G. K.; Patnaik, A.; Gore, L.; Wu, L.; Vassilev, L. T.; Ding, M.; Geho, D.; Zhi, J.; Middleton, S.; Nichols, G. L. |
| Abstract Title: | A phase I study of MDM2 antagonist RG7112 in patients (pts) with relapsed/refractory solid tumors |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009802223 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.e13600 |
| Notes: | Meeting Abstract: e13600^ -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
